KNG1 and autoimmune polyendocrinopathy: Antibodies directed against high molecular weight kininogen bound to neutral PL such as phosphatidylethanolamine (PE) have been reported, but their usefulness is limited to a handful of cases with clinical manifestations similar to those present in APS (59).